Live Breaking News & Updates on Geron Corporation Nasdaq

Stay updated with breaking news from Geron corporation nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Geron Announces FDA Approval of RYTELO (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

07.06.2024 - Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved RYTELO (imetelstat) for the . Seite 1 ....

Johna Scarlett , Geron Corporation Nasdaq , Drug Administration , Geron Corporation , Chief Executive ,

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Aaron Feingold , Kristen Kelleher , European Union , Drug Administration , Corporate Communications , Geron Corporation , Geron Corporation Nasdaq , Nasdaq Listing Rule , Award Plan , Nobel Prize Winning , New Drug Application , United States Food , Prescription Drug User Fee Act , Investor Relations ,